162 related articles for article (PubMed ID: 30254824)
1. 'Bleeding Dilemma': The Story of a Periampullary Mass.
Bahl B; Vadlamudi R; Yedla P; Smalligan RD
Cureus; 2018 Jul; 10(7):e3035. PubMed ID: 30254824
[TBL] [Abstract][Full Text] [Related]
2. A rare synchrony of adenocarcinoma of the ampulla with an ileal gastrointestinal stromal tumor: A case report.
Matli VVK; Zibari GB; Wellman G; Ramadas P; Pandit S; Morris J
World J Gastrointest Oncol; 2022 Nov; 14(11):2253-2265. PubMed ID: 36438708
[TBL] [Abstract][Full Text] [Related]
3. [Surgery for periampullary pancreatic cancer].
Hank T; Klaiber U; Sahora K; Schindl M; Strobel O
Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884
[TBL] [Abstract][Full Text] [Related]
4. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract][Full Text] [Related]
5. A Case of Pedunculated Adenoma of the Bile Duct Proving Adenoma to Cancer Sequence.
Ahsan M; Jarbath M; Davis B; Provance WJ
Cureus; 2024 Apr; 16(4):e58304. PubMed ID: 38752036
[TBL] [Abstract][Full Text] [Related]
6. [Ampullary Carcinoma-prognostic and Therapeutical Contrast to Pancreatic Ductal Adenocarcinoma].
Giehl-Brown E; Weitz J; Distler M
Zentralbl Chir; 2022 Apr; 147(2):160-167. PubMed ID: 35378556
[TBL] [Abstract][Full Text] [Related]
7. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
8. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Ampullary Adenocarcinoma].
Shin DW
Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
[TBL] [Abstract][Full Text] [Related]
10. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
11. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
12. Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges.
Rizzo A; Dadduzio V; Lombardi L; Ricci AD; Gadaleta-Caldarola G
Curr Oncol; 2021 Sep; 28(5):3393-3402. PubMed ID: 34590592
[TBL] [Abstract][Full Text] [Related]
13. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of survival in ampullary carcinoma.
Howe JR; Klimstra DS; Moccia RD; Conlon KC; Brennan MF
Ann Surg; 1998 Jul; 228(1):87-94. PubMed ID: 9671071
[TBL] [Abstract][Full Text] [Related]
15. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
Chandrasegaram MD; Gill AJ; Samra J; Price T; Chen J; Fawcett J; Merrett ND
World J Gastrointest Oncol; 2017 Oct; 9(10):407-415. PubMed ID: 29085567
[TBL] [Abstract][Full Text] [Related]
16. Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.
Panzeri F; Crippa S; Castelli P; Aleotti F; Pucci A; Partelli S; Zamboni G; Falconi M
World J Gastroenterol; 2015 Jul; 21(26):7970-87. PubMed ID: 26185369
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the Ampulla of Vater Associated with Annular Pancreas.
Tewari M; Verma A; Shukla HS
Indian J Surg; 2016 Oct; 78(5):409-410. PubMed ID: 27994339
[TBL] [Abstract][Full Text] [Related]
18. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
19. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.
Komine R; Kojima M; Ishi G; Kudo M; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Kobayashi T; Akimoto T; Murakami A; Sasaki M; Tanaka M; Matsuzaki A; Ohike N; Uchida K; Sugiyama T; Hirabayashi K; Tajiri T; Ishida K; Kai K; Omori Y; Notohara K; Yamaguchi H; Matsuda Y; Naito Y; Fukumura Y; Hamada Y; Mihara Y; Masugi Y; Gotohda N; Harada K; Fukushima N; Furukawa T
Cancer Med; 2021 Jun; 10(11):3499-3510. PubMed ID: 34008914
[TBL] [Abstract][Full Text] [Related]
20. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
